SE425782B - Sett att framstella n-substituerade laktamer med verdefulla farmaceutiska egenskaper - Google Patents

Sett att framstella n-substituerade laktamer med verdefulla farmaceutiska egenskaper

Info

Publication number
SE425782B
SE425782B SE7711667A SE7711667A SE425782B SE 425782 B SE425782 B SE 425782B SE 7711667 A SE7711667 A SE 7711667A SE 7711667 A SE7711667 A SE 7711667A SE 425782 B SE425782 B SE 425782B
Authority
SE
Sweden
Prior art keywords
make
pharmaceutical properties
valuable pharmaceutical
substituted lactams
lactams
Prior art date
Application number
SE7711667A
Other languages
English (en)
Other versions
SE7711667L (sv
Inventor
L Rodriguez
L Marchal
Original Assignee
Ucb Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ucb Sa filed Critical Ucb Sa
Publication of SE7711667L publication Critical patent/SE7711667L/sv
Publication of SE425782B publication Critical patent/SE425782B/sv

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
    • C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D207/18—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member
    • C07D207/22—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D207/24—Oxygen or sulfur atoms
    • C07D207/26—2-Pyrrolidones
    • C07D207/263—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms
    • C07D207/27—2-Pyrrolidones with only hydrogen atoms or radicals containing only hydrogen and carbon atoms directly attached to other ring carbon atoms with substituted hydrocarbon radicals directly attached to the ring nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/06—Antianaemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D223/00—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom
    • C07D223/02—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings
    • C07D223/06—Heterocyclic compounds containing seven-membered rings having one nitrogen atom as the only ring hetero atom not condensed with other rings with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D223/08—Oxygen atoms
    • C07D223/10—Oxygen atoms attached in position 2

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Biomedical Technology (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyrrole Compounds (AREA)
  • Hydrogenated Pyridines (AREA)
  • Cephalosporin Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
SE7711667A 1976-10-22 1977-10-17 Sett att framstella n-substituerade laktamer med verdefulla farmaceutiska egenskaper SE425782B (sv)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB43934/76A GB1539817A (en) 1976-10-22 1976-10-22 N-substituted lactams

Publications (2)

Publication Number Publication Date
SE7711667L SE7711667L (sv) 1978-04-23
SE425782B true SE425782B (sv) 1982-11-08

Family

ID=10431009

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7711667A SE425782B (sv) 1976-10-22 1977-10-17 Sett att framstella n-substituerade laktamer med verdefulla farmaceutiska egenskaper

Country Status (27)

Country Link
US (1) US4162325A (sv)
JP (1) JPS5839148B2 (sv)
AT (1) AT352742B (sv)
BE (1) BE859925A (sv)
BG (1) BG28413A3 (sv)
CA (1) CA1095040A (sv)
CH (1) CH625214A5 (sv)
CS (1) CS200231B2 (sv)
CY (1) CY1037A (sv)
DD (1) DD131930A5 (sv)
DE (1) DE2747369A1 (sv)
DK (1) DK461877A (sv)
ES (1) ES463424A1 (sv)
FI (1) FI66600C (sv)
FR (1) FR2368474B1 (sv)
GB (1) GB1539817A (sv)
HK (1) HK2380A (sv)
HU (1) HU174864B (sv)
IL (1) IL53171A (sv)
KE (1) KE3013A (sv)
MY (1) MY8000264A (sv)
NL (1) NL7711414A (sv)
PL (1) PL110679B1 (sv)
SE (1) SE425782B (sv)
SU (2) SU805945A3 (sv)
YU (1) YU251977A (sv)
ZA (1) ZA776260B (sv)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2960194D1 (en) * 1978-05-08 1981-04-16 Ucb Sa Lactam-n-acetic acids, their amides, process for their preparation and therapeutic compositions containing them
FI840261A (fi) * 1983-01-27 1984-07-28 Ciba Geigy Ag Substituerade pyrrolidinonderivat och foerfarande foer deras framstaellning.
FI840260A (fi) * 1983-01-27 1984-07-28 Ciba Geigy Ag Pyrrolidinonderivat och foerfarande foer deras framstaellning.
IT1190378B (it) * 1985-06-21 1988-02-16 Isf Spa Derivati pirrolidonici
US5118811A (en) * 1989-04-13 1992-06-02 Japan Tobacco Inc. Amino acid derivatives possessing prolyl endopeptidase-inhibitory activities
US5206386A (en) * 1991-03-20 1993-04-27 Isp Investments Inc. Controlled release N-substituted pyrrolidone esters and process for the use thereof
DE4308034A1 (de) * 1993-03-13 1994-09-15 Cassella Ag Neue Heterocyclen, ihre Herstellung und ihre Verwendung
US5658940A (en) * 1995-10-06 1997-08-19 Celgene Corporation Succinimide and maleimide cytokine inhibitors
US5914332A (en) * 1995-12-13 1999-06-22 Abbott Laboratories Retroviral protease inhibiting compounds
CN114685342B (zh) * 2020-12-25 2024-05-10 长沙博源医疗科技有限公司 一种左乙拉西坦衍生物、免疫原、抗左乙拉西坦特异性抗体及其制备方法与应用

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3121723A (en) * 1955-11-02 1964-02-18 Sterling Drug Inc Lower alkyl n-(tertiary-amino-lower-alkyl) lower alkamates and quaternary ammonium salts thereof
GB1039113A (en) * 1964-08-06 1966-08-17 Ucb Sa New n-substituted lactams
NL7407140A (nl) * 1974-03-07 1975-09-09 Jose Maria Espinos Taya En Jos Werkwijze voor de bereiding van een n-gesub- stitueerd pyrrolidon.
AT360980B (de) * 1976-01-14 1981-02-10 Pliva Pharm & Chem Works Verfahren zur herstellung von n-alkylamiden des 2-oxo-1-pyrrolidins

Also Published As

Publication number Publication date
DE2747369C2 (sv) 1987-11-12
CH625214A5 (sv) 1981-09-15
FI66600C (fi) 1984-11-12
BG28413A3 (en) 1980-04-15
DD131930A5 (de) 1978-08-09
NL7711414A (nl) 1978-04-25
JPS5353649A (en) 1978-05-16
MY8000264A (en) 1980-12-31
CA1095040A (en) 1981-02-03
ATA749677A (de) 1979-03-15
FI773069A (fi) 1978-04-23
US4162325A (en) 1979-07-24
ZA776260B (en) 1978-07-26
IL53171A0 (en) 1977-12-30
DK461877A (da) 1978-04-23
CS200231B2 (en) 1980-08-29
FR2368474B1 (fr) 1980-08-08
IL53171A (en) 1982-02-28
DE2747369A1 (de) 1978-04-27
HU174864B (hu) 1980-03-28
PL110679B1 (en) 1980-07-31
YU251977A (en) 1983-01-21
AT352742B (de) 1979-10-10
SU805945A3 (ru) 1981-02-15
PL201601A1 (pl) 1979-01-29
FI66600B (fi) 1984-07-31
JPS5839148B2 (ja) 1983-08-27
CY1037A (en) 1980-08-01
HK2380A (en) 1980-01-25
KE3013A (en) 1980-02-01
FR2368474A1 (sv) 1978-05-19
BE859925A (fr) 1978-04-20
ES463424A1 (es) 1978-07-16
SU937450A1 (ru) 1982-06-23
GB1539817A (en) 1979-02-07
SE7711667L (sv) 1978-04-23

Similar Documents

Publication Publication Date Title
SE431935B (sv) Sett att framstella drageer
SE433222B (sv) Sett att framstella modifierad polysackarid
SE440149B (sv) Sett att sammankoppla biologiska substanser med bensokinon
SE432247B (sv) Sett att framstella dihydro-cyklosporin c
SE422077B (sv) Sett att framstella syntesgas
SE7805276L (sv) Sett att framstella liposomblandningar
SE440779B (sv) Sett att framstella androstan-17-on-derivat
SE7606280L (sv) Sett att framstella etrar
SE433492B (sv) Sett att framstella fenylettiksyraderivat
SE430248B (sv) Sett att framstella vissa n-substituerade bensensulfonamider
SE425736B (sv) Sett att framstella kromanon-(4)
SE420728B (sv) Sett att framstella piperazinyliminorifamyciner
SE432256B (sv) Sett att framstella cellulosaalkyletrar
SE430687B (sv) Sett att framstella hexanitrostilben
SE425782B (sv) Sett att framstella n-substituerade laktamer med verdefulla farmaceutiska egenskaper
SE416239B (sv) Sett att identifiera fluorescensemnen
SE429438B (sv) Sett att framstella flexibla sprengemnesformkroppar
SE420732B (sv) Sett att framstella 4-gonen-3-oner
SE430156B (sv) Sett att framstella 2-subst-1-(omega-aminoalkoxi)-bensener
SE434397B (sv) Sett att framstella bens-acyl-bensimidazol-2-derivat
SE415971B (sv) Sett att framstella substituerade bensamider med terapeutisk verkan
SE7609269L (sv) Sett att framstella polymerblandningar
SE427655B (sv) Sett att framstella abietamidderivat
SE7608939L (sv) Sett att framstella pyrrolinderivat
SE7607171L (sv) Sett att framstella indolokinoliziner